KR102222846B1 - Fermented black rice powder having antioxidant ability or nerve cell protective ability and the method for manufacturing the same - Google Patents
Fermented black rice powder having antioxidant ability or nerve cell protective ability and the method for manufacturing the same Download PDFInfo
- Publication number
- KR102222846B1 KR102222846B1 KR1020190013020A KR20190013020A KR102222846B1 KR 102222846 B1 KR102222846 B1 KR 102222846B1 KR 1020190013020 A KR1020190013020 A KR 1020190013020A KR 20190013020 A KR20190013020 A KR 20190013020A KR 102222846 B1 KR102222846 B1 KR 102222846B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- black rice
- fermented
- lactic acid
- acid bacteria
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 105
- 241000371652 Curvularia clavata Species 0.000 title claims abstract description 88
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 210000002569 neuron Anatomy 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 8
- 230000001681 protective effect Effects 0.000 title abstract description 12
- 239000003963 antioxidant agent Substances 0.000 title description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 241000894006 Bacteria Species 0.000 claims abstract description 22
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 19
- 239000004310 lactic acid Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 230000003859 lipid peroxidation Effects 0.000 claims description 8
- 241000192130 Leuconostoc mesenteroides Species 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 2
- 206010020772 Hypertension Diseases 0.000 claims description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 230000003449 preventive effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000001537 neural effect Effects 0.000 abstract description 6
- 239000000284 extract Substances 0.000 description 31
- 210000004027 cell Anatomy 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 9
- 230000036542 oxidative stress Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- 230000004792 oxidative damage Effects 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 4
- 241000209094 Oryza Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 4
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000017066 negative regulation of growth Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- LJJZKMDEQVYRJX-UHFFFAOYSA-N 4,5,6-tripyridin-2-yltriazine Chemical compound N1=CC=CC=C1C1=NN=NC(C=2N=CC=CC=2)=C1C1=CC=CC=N1 LJJZKMDEQVYRJX-UHFFFAOYSA-N 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 101100094857 Danio rerio slc22a6 gene Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 231100000416 LDH assay Toxicity 0.000 description 1
- 238000003222 MTT reduction assay Methods 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101150010952 OAT gene Proteins 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 229910001447 ferric ion Inorganic materials 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- XVFMGWDSJLBXDZ-UHFFFAOYSA-O pelargonidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 XVFMGWDSJLBXDZ-UHFFFAOYSA-O 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- XFDQJKDGGOEYPI-UHFFFAOYSA-O peonidin Chemical compound C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 XFDQJKDGGOEYPI-UHFFFAOYSA-O 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/31—Leuconostoc
- A23V2400/321—Mesenteroides
-
- A23Y2260/35—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은, 흑미를 특정 유산균으로 발효함으로써, 뛰어난 항산화 효과와 신경세포 보호효과를 발현시킬 수 있는 흑미 발효분말 및 그 제조방법에 관한 것이다.The present invention relates to a fermented black rice powder capable of expressing an excellent antioxidant effect and neuronal protective effect by fermenting black rice with specific lactic acid bacteria, and a method for producing the same.
Description
본 발명은 항산화능 또는 신경세포 보호능을 가지는 흑미 발효분말 및 그 제조방법에 관한 것이다.The present invention relates to a fermented black rice powder having antioxidant activity or neuronal cell protection, and a method for producing the same.
인체 조직세포의 산화적 스트레스는 심혈관계 질환의 발병 기전에 중요한 역할을 할 뿐 아니라, 자유라디칼(free radical)에 의해 유도된 산화적 스트레스는 혈관의 확장과 수축의 조화를 깨뜨리고 생체막의 과산화지질을 증가시키며, 조직세포에 산화적 손상을 주어 동맥경화, 당뇨병 및 고혈압 등 각종 질환을 유발시키는 것으로 알려져 있다.The oxidative stress of human tissue cells not only plays an important role in the pathogenesis of cardiovascular disease, but also the oxidative stress induced by free radicals breaks the harmony between the expansion and contraction of blood vessels and reduces the lipid peroxidation of the biological membrane. It is known to cause various diseases such as arteriosclerosis, diabetes and hypertension by causing oxidative damage to tissue cells.
한편, 한국인의 주식인 쌀에는 토코페롤(tocopherol), 토코트리에놀(tocotrienol, 감마-오리자놀(γ-oryzanol) 및 피틴산 등 항산화 성분을 비롯하여 식이섬유 등 다양한 생리활성 성분이 함유되어 있는 것으로 알려져 있다. 특히, 유색미의 일종인 흑미(black rice)에는 천연 색소 성분인 안토시아닌(anthocyanin)이 풍부하여 항염증, 항산화, 항균 및 항암 등의 다양한 생리활성이 있는 것으로 알려져 있다. 구체적으로, 흑미에서 확인된 안토시아닌은 cyanidin, peonidin, malvidin, pelargonidin flavylium 및 이들의 배당체로 이들은 α-토코페롤(tocopherol)과 유사한 수준의 항산화능을 지니고 있음이 보고되었다(Cho MH et, al. 1996).On the other hand, rice, a staple food of Koreans, is known to contain various physiologically active ingredients such as dietary fiber, as well as antioxidants such as tocopherol, tocotrienol, gamma-oryzanol, and phytic acid. Black rice, a kind of black rice, is known to have various physiological activities, such as anti-inflammatory, antioxidant, antibacterial, and anti-cancer, as it is rich in anthocyanin, a natural pigment component. As peonidin, malvidin, pelargonidin flavylium and their glycosides, it has been reported that they have an antioxidant activity similar to that of α-tocopherol (Cho MH et, al. 1996).
한편, 본 발명자들은 흑미를 특정 유산균으로 발효한 발효분말이 뛰어난 항산화 효과와 신경세포 보호효과를 발현시킬 수 있다는 점을 실험을 통해 확인하고 본 발명을 완성하게 되었다.On the other hand, the present inventors confirmed through an experiment that the fermented powder obtained by fermenting black rice with a specific lactic acid bacteria can express excellent antioxidant effects and neuronal protective effects, and completed the present invention.
본 발명은, 흑미를 특정 유산균으로 발효함으로써, 뛰어난 항산화 효과와 신경세포 보호효과를 발현시킬 수 있는 흑미 발효분말 및 그 제조방법을 제공하고자 한다.An object of the present invention is to provide a fermented black rice powder capable of expressing excellent antioxidant effect and neuronal protective effect by fermenting black rice with specific lactic acid bacteria and a method for producing the same.
상기와 같은 목적을 달성하기 위하여, 본 명세서에서는, 흑미 분말, 단백 분말, 정제수 및 동결 건조된 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 유산균 분말을 배합하고, 20일 내지 40일 간 발효하는 단계를 포함하는, 흑미 발효분말의 제조방법을 제공한다. In order to achieve the above object, in the present specification, a step of mixing black rice powder, protein powder, purified water, and freeze-dried Leuconostoc mesenteroides lactic acid bacteria powder, and fermenting for 20 to 40 days It provides a method for producing fermented black rice powder containing.
또한, 본 명세서에서는 상기 방법에 따라 제조된 흑미 발효분말로서, 상기 분말은 유산균 함량이 1,000,000 cfu/g 이상인, 흑미 발효분말을 제공한다.In addition, in the present specification, as a fermented black rice powder prepared according to the above method, the powder provides a fermented black rice powder having a lactic acid bacteria content of 1,000,000 cfu/g or more.
이하, 본 발명의 구체적인 실시예에 따른 흑미 발효분말 및 그 제조방법에 대하여 보다 상세히 설명한다.Hereinafter, a fermented black rice powder and a manufacturing method thereof according to a specific embodiment of the present invention will be described in more detail.
상술한 바와 같이, 본 발명의 일실시예에 따르면, 흑미 분말, 단백 분말, 정제수 및 동결 건조된 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 유산균 분말을 배합하고, 20일 내지 40일 간 발효하는 단계를 포함하는, 흑미 발효분말의 제조방법이 제공될 수 있다. As described above, according to an embodiment of the present invention, mixing black rice powder, protein powder, purified water, and freeze-dried Leuconostoc mesenteroides lactic acid bacteria powder, and fermenting for 20 to 40 days Including, a method for producing fermented black rice powder may be provided.
본 발명자들은, 흑미를 특정 유산균으로 발효하되, 특정 온도 및 특정 시간 동안 발효하는 경우, 뛰어난 항산화 효과와 신경세포 보호효과를 발현시킬 수 있다는 점을 실험을 통하여 확인하고 본 발명을 완성하였다. The inventors of the present invention confirmed through an experiment that black rice can be fermented with a specific lactic acid bacteria, but when fermented for a specific temperature and a specific time, an excellent antioxidant effect and a neuroprotective effect can be expressed through experiments, and the present invention was completed.
본 발명의 일실시예에 따른, 흑미는 유색미의 일종으로서, 천연 색소 성분인 안토시아닌(anthocyanin)이 풍부하여 항염증, 항산화, 항균 및 항암 등의 다양한 생리활성이 있다. 구체적으로 본 발명에서 사용되는 흑미는 분말(powder) 형태로 사용될 수 있다.According to an embodiment of the present invention, black rice is a kind of colored rice and is rich in anthocyanin, a natural pigment component, and has various physiological activities such as anti-inflammatory, antioxidant, antibacterial and anti-cancer. Specifically, the black rice used in the present invention may be used in the form of a powder.
한편, 본 발명의 일실시예에 따른, 단백 분말은 유산균의 생육 및 생장을 돕기 위한 것으로서, 구체적으로 쌀단백, 대두단백, 완두단백, 귀리단백, 호박단백 등 식물성 단백질 중 선택되는 1종 이상의 원료를 이용하여, 다양한 건조방법으로 제조된 분말일 수 있다. On the other hand, the protein powder according to an embodiment of the present invention is to help the growth and growth of lactic acid bacteria, specifically, one or more raw materials selected from vegetable proteins such as rice protein, soy protein, pea protein, oat protein, pumpkin protein, etc. Using, it may be a powder prepared by various drying methods.
한편, 상기 단계에서 사용되는 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 유산균은 우리나라의 대표적인 전통발효식품인 "김치"에서 발굴된 식물성 유산균으로서, 정장작용, 유해균 증식억제 및 배변활동 원활 등의 효과가 있는 것으로 알려져 있다. On the other hand, Leuconostoc mesenteroides lactic acid bacteria used in the above step are plant lactic acid bacteria discovered in "Kimchi," a representative traditional fermented food in Korea, and have effects such as intestinal function, inhibition of growth of harmful bacteria and smooth bowel movement. It is known to have.
구체적으로 본 발명의 일실시예에 따르면, 상기 단계에서 배합 시 분말 전체 중량을 기준으로, 흑미 분말은 20 내지 30wt%, 단백 분말은 20 내지 30wt%, 정제수는 45 내지 55wt% 및 동결 건조된 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 유산균 분말은 0.005 내지 0.015 wt%로 배합되는 것일 수 있다. Specifically, according to an embodiment of the present invention, based on the total weight of the powder when blended in the above step, black rice powder is 20 to 30wt%, protein powder is 20 to 30wt%, purified water is 45 to 55wt%, and freeze-dried Cono Stock mesenteroides (Leuconostoc mesenteroides ) lactic acid bacteria powder may be blended in an amount of 0.005 to 0.015 wt%.
한편, 상기 단계에서, 발효 기간은 20 내지 40일 범위 내, 더욱 상세하게는 20 내지 22일 간 발효가 수행될 수 있으며, 상기 기간 동안 발효되는 경우 유산균 증식 및 효소활성 증대를 통해 정장작용, 유해균 증식억제, 배변활동 원활 및 소화촉진 효과 등 유익한 효과를 효과적으로 발현케 할 수 있다. 또한, 상기 단계에서, 발효 온도는 35 내지 37℃일 수 있으며, 상기 온도 범위 내에서 발효되는 경우 유산균 증식 및 효소활성 증대를 통해 정장작용, 유해균 증식억제, 배변활동 원활 및 소화촉진 효과 등 유익한 효과를 효과적으로 발현케 할 수 있다. Meanwhile, in the above step, the fermentation period may be within the range of 20 to 40 days, and more specifically, fermentation may be performed for 20 to 22 days, and in the case of fermentation during the period, intestinal action, harmful bacteria through the growth of lactic acid bacteria and enhancement of enzyme activity It can effectively express beneficial effects such as inhibition of proliferation, smooth bowel movement and promotion of digestion. In addition, in the above step, the fermentation temperature may be 35 to 37 °C, and when fermented within the above temperature range, beneficial effects such as intestinal action, inhibition of growth of harmful bacteria, smooth bowel movement and digestion promotion effect through increase of lactic acid bacteria growth and enzyme activity Can be effectively expressed.
본 발명의 일실시예에 따른 흑미 발효분말의 제조방법에서는, 상기 발효 단계 후, 상기 발효분말을 동결 건조한 다음, 분쇄하는 단계를 더 포함할 수 있다. In the manufacturing method of the fermented black rice powder according to an embodiment of the present invention, after the fermentation step, the fermented powder may be freeze-dried and then pulverized.
구체적으로, 상기 동결 건조 및 분쇄 방법은 당해 기술분야에서 일반적으로 사용되는 방법으로 수행될 수 있으며, 특별히 제한되는 것은 아니다. 상기 단계를 통해 분쇄된 흑미 발효분말의 직경은 일례로 250 μm 이하일 수 있다. Specifically, the freeze drying and pulverization method may be performed by a method generally used in the art, and is not particularly limited. The diameter of the fermented black rice powder pulverized through the above step may be 250 μm or less, for example.
상술한 바와 같은 본 발명의 일실시예에 따른 방법으로 제조한 흑미 발효분말은, 유산균 함량이 1,000,000 cfu/g 이상일 수 있다. 또한, 상술한 바와 같은 본 발명의 일실시예에 따른 방법으로 제조한 흑미 발효분말은 항산화능 또는 신경세포 보호능을 가진다.The fermented black rice powder prepared by the method according to an embodiment of the present invention as described above may have a lactic acid bacteria content of 1,000,000 cfu/g or more. In addition, the fermented black rice powder prepared by the method according to an embodiment of the present invention as described above has antioxidant activity or neuronal cell protection.
본 발명에 따라 제조된 흑미 발효분말은 항산화능을 가지며, 세포의 산화적 손상을 방지하는 효과가 있다. 특히, 본 발명에 따른 흑미 발효분말은 신경세포 보호능을 가진다.The fermented black rice powder prepared according to the present invention has antioxidant properties and has an effect of preventing oxidative damage to cells. In particular, the fermented black rice powder according to the present invention has the ability to protect nerve cells.
도 1은 본 발명의 일실시예에 따라 제조한 흑미 발효분말 10% 용액의 발효기간에 따른 pH를 측정한 결과를 나타낸 그래프이다.
도 2는 본 발명의 일실시예에 따라 제조한 흑미 발효분말 물추출물의 농도별 ABTS 라디칼 소거활성을 나타낸 그래프이다.
도 3은 본 발명의 일실시예에 따라 제조한 흑미 발효분말 물추출물의 농도별 ferric reducing antioixdant power를 나타낸 그래프이다.
도 4는 본 발명의 일실시예에 따라 제조한 흑미 발효분말 물추출물의 농도별 지질과산화억제 활성을 나타낸 그래프이다.
도 5는 본 발명의 일실시예에 따라 제조한 흑미 발효분말 물추출물의 농도별 산화적 스트레스 상태에서 신경세포 생존율을 나타낸 그래프이다.
도 6은 본 발명의 일실시예에 따라 제조한 흑미 발효분말 물추출물의 농도별 세포막 손상 억제 효과를 나타낸 그래프이다.
도 7은 본 발명의 일실시예에 따라 제조한 흑미 발효분말 물추출물의 농도별 세포 내 ROS 생성 저해 활성을 나타낸 그래프이다.1 is a graph showing the result of measuring the pH according to the fermentation period of a 10% solution of fermented black rice powder prepared according to an embodiment of the present invention.
Figure 2 is a graph showing the ABTS radical scavenging activity by concentration of the black rice fermented powder water extract prepared according to an embodiment of the present invention.
3 is a graph showing ferric reducing antioixdant power by concentration of water extract of fermented black rice powder prepared according to an embodiment of the present invention.
Figure 4 is a graph showing the lipid peroxidation inhibitory activity by concentration of the black rice fermented powder water extract prepared according to an embodiment of the present invention.
FIG. 5 is a graph showing the survival rate of neurons in oxidative stress conditions according to concentrations of water extract of fermented black rice powder prepared according to an embodiment of the present invention.
6 is a graph showing the effect of inhibiting cell membrane damage by concentration of water extract of fermented black rice powder prepared according to an embodiment of the present invention.
7 is a graph showing intracellular ROS production inhibitory activity according to concentrations of water extract of fermented black rice powder prepared according to an embodiment of the present invention.
본 발명은 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있는 바, 특정 실시예들을 예시하고 하기에서 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 개시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.The present invention will be described in detail below and exemplify specific embodiments, as various modifications can be made and various forms can be obtained. However, this is not intended to limit the present invention to a specific form disclosed, it should be understood to include all changes, equivalents, and substitutes included in the spirit and scope of the present invention.
실시예 1. 흑미 발효분말의 제조방법Example 1. Method for producing fermented black rice powder
먼저, 흑미 분말 250g, 쌀단백 분말 250g, 정제수 499.85g 및 동결건조 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 유산균 분말 0.15g을 혼합한 다음, 항온항습 환경에서 20일 간 37℃ 온도로 발효하였다. 다음으로, 상기 얻어진 발효분말을 호기성 병원성 미생물이 생육하기 어려운 진공조건에서 동견건조기를 이용하여 동결 건조한 다음, 분쇄기를 이용하여 분쇄하여, 발효분말의 직경이 250 μm 이하가 되도록 하였다. First, 250 g of black rice powder, 250 g of rice protein powder, 499.85 g of purified water, and 0.15 g of freeze-dried Leuconostoc mesenteroides lactic acid bacteria powder were mixed, and then fermented at a temperature of 37° C. for 20 days in a constant temperature and humidity environment. Next, the obtained fermented powder was freeze-dried using a cochlear dryer under vacuum conditions in which aerobic pathogenic microorganisms are difficult to grow, and then pulverized using a grinder, so that the diameter of the fermented powder was 250 μm or less.
실시예 2. 흑미 발효분말 물추출물 제조Example 2. Preparation of water extract of fermented black rice powder
상기 실시예 1에 따라 제조된 흑미 발효분말 100 g에 증류수 900 mL를 첨가하여 24시간 침지하여 추출하였다. 추출된 용액을 진공회전농축기를 이용하여 농축 후 동결건조하여 하기 실험에 사용하였다.900 mL of distilled water was added to 100 g of the fermented black rice powder prepared according to Example 1, followed by immersion for 24 hours for extraction. The extracted solution was concentrated using a vacuum rotary concentrator and then freeze-dried and used in the following experiment.
실험 1: pH 측정Experiment 1: pH measurement
상기 실시예 2의 흑미 발효분말 물추출물(10% 용액)을 pH meter(Orion star A211, Thermo scientific Co., USA)를 이용하여 측정하였다(도 1 참조). The black rice fermented powder water extract (10% solution) of Example 2 was measured using a pH meter (Orion star A211, Thermo scientific Co., USA) (see FIG. 1).
도 1의 결과를 참조하면, 발효 기간 0일째에는 pH가 5.81이었으나 발효 기간이 경과함에 따라 점차적으로 pH가 점차적으로 감소하는 경향을 보였으며, 발효 20일째는 pH가 4.48로 나타났는데, 이는 발효 중 유산균의 증식으로 인한 결과로 판단된다. Referring to the results of FIG. 1, the pH was 5.81 on
실험 2: ABTS 라디칼 소거활성Experiment 2: ABTS radical scavenging activity
7 mM ABTS 5 mL와 140 mM K2S2O8 88 μL를 섞어 어두운 곳에 14 내지 16시간 방치시킨 후, 이를 무수 에탄올과 약 1 : 88(v/v) 비율로 섞어 734 nm에서 대조구의 흡광도 값이 0.7±0.02가 되도록 조절한 ABTS 용액을 사용하였다. 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물 20 μL와 ABTS 용액 980 μL를 혼합하여 30초간 진탕한 후 2.5분간 반응시키고, 734 nm에서 흡광도를 측정하여 라디칼 소거활성을 나타내었다(도 2 참조). Mix 5 mL of 7 mM ABTS and 88 μL of 140 mM K 2 S 2 O 8 and leave for 14 to 16 hours in a dark place, mix this with absolute ethanol at a ratio of about 1: 88 (v/v), and absorb the absorbance of the control at 734 nm. The ABTS solution adjusted to a value of 0.7±0.02 was used. Mixing 20 μL of the black rice fermented powder water extract by concentration prepared using the black rice fermented powder of Example 1 and 980 μL of ABTS solution, shaking for 30 seconds, reacting for 2.5 minutes, and measuring the absorbance at 734 nm for radical scavenging activity Is shown (see Fig. 2).
도 2의 결과를 참조하면, 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물을 이용하여 ABTS 라디칼 소거활성을 측정한 결과 추출물의 농도가 증가함에 따라 점차적으로 ABTS 라디칼 소거활성 역시 농도 의존적으로 증가하는 경향을 나타내었으며, 농도 1,000 μg/mL에서는 양성대조군으로 사용한 vitamin C와 유사한 경향을 보였다. Referring to the results of FIG. 2, as a result of measuring ABTS radical scavenging activity using the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1, the ABTS radicals gradually increased as the concentration of the extract increased. The scavenging activity also showed a tendency to increase in a concentration-dependent manner, and at a concentration of 1,000 μg/mL, it showed a similar tendency to vitamin C used as a positive control.
실험 3: Ferric reducing antioxidant power Experiment 3: Ferric reducing antioxidant power
FRAP assay에 사용된 시약은 0.3 M sodium acetate buffer (pH 3.6)와 40 mM HCl로 용해시킨 10 mM 2,4,6-tripyridyl-S-triazine (TPTZ) solution, 그리고 20 mM FeCl3 solution을 사용하였다. 미리 제조된 sodium acetate buffer, TPTZ solution 및 FeCl3 solution을 각각 10 : 1 : 1(v/v/v)의 비율로 혼합하여 37℃에서 10-15분간 incubation 시켜 FRAP reagent를 준비하였다. FRAP reagent 1.5 mL를 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물 50 μL에 혼합하여 vortex하여 실온에서 30분간 방치한 후 593 nm에서 흡광도를 측정하였다(도 3 참조). Reagents used in the FRAP assay were 0.3 M sodium acetate buffer (pH 3.6), 10
FRAP assay는 시료 내에 존재하는 항산화물질에 의해 ferric ion이 ferrous ion으로 환원됨으로써 얻어지는 colored ferrous tripyridyl triazine complex를 593 nm에서 흡광도를 측정함으로써 항산화력을 측정하는 방법인데, 도 3의 결과를 참조하면, FRAP도 ABTS 라디칼 소거활성과 동일하게 흑미 발효분말 물추출물의 첨가 농도가 증가함에 따라 흡광도 값이 증가하는 경향을 보였다.FRAP assay is a method of measuring the antioxidant power by measuring the absorbance at 593 nm of a colored ferrous tripyridyl triazine complex obtained by reducing ferric ions to ferrous ions by antioxidants present in the sample.Refer to the results of FIG. In the same manner as in the ABTS radical scavenging activity, the absorbance value tended to increase as the concentration of the water extract of the fermented black rice powder increased.
실험 4: 지질과산화 억제활성Experiment 4: lipid peroxidation inhibitory activity
뇌 부위 조직을 10 volume의 ice cold Tris-HCl buffer (20 mM, pH 7.4)에 균질화시킨 후 4℃에서 15분간 12,000 × g으로 원심분리하였다. 상등액 0.1 mL에 10 μM FeSO4 0.1 mL, 0.1 mM ascorbic acid 0.1 mL 및 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물 0.2 mL를 첨가하여 37℃에서 1시간 동안 배양하였다. 이 반응액에 28% trichloroacetic acid 0.1 mL를 첨가하여 반응을 종결시키고, 1% thiobarbituric acid 0.3 mL를 첨가하여 80℃에서 30분간 가열한 후 532 nm에서 흡광도를 측정하였다(도 4 참조). The brain tissue was homogenized in 10 volumes of ice cold Tris-HCl buffer (20 mM, pH 7.4) and centrifuged at 12,000 × g for 15 minutes at 4°C. To 0.1 mL of the supernatant, 0.1 mL of 10 μM FeSO 4, 0.1 mL of 0.1 mM ascorbic acid, and 0.2 mL of the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 were added and incubated at 37°C for 1 hour. I did. 0.1 mL of 28% trichloroacetic acid was added to the reaction solution to terminate the reaction, 0.3 mL of 1% thiobarbituric acid was added, heated at 80° C. for 30 minutes, and absorbance was measured at 532 nm (see FIG. 4).
유해 활성산소에 의한 뇌조직의 산화적 손상에 있어서 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물에 의한 지질 과산화 억제 효과를 분석하였는데, 이는 뇌조직이 다른 장기에 비하여 특히 불포화 지방산의 함량이 높은 관계로 산화적 손상의 변화를 조사하기가 유리하고, 지질성분의 산화가 세포막 손상 및 기타 단백질 손상과도 관계가 깊어 본 실험을 진행하였다. 도 4를 참조하면, 마우스 뇌 homogenate를 이용하여 지질과산화 억제활성을 측정한 결과 위의 2가지 항산화 활성결과와 유사하게 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물의 첨가농도가 증가함에 따라 뇌조직의 지질과산화가 매우 억제되는 것으로 나타났으며, 특히 1,000 μg/mL를 첨가한 시료에서는 76.25%의 매우 높은 지질과산화 억제활성을 보였다. In the oxidative damage of brain tissues caused by harmful free radicals, the inhibitory effect on lipid peroxidation by the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 was analyzed. In contrast, since the content of unsaturated fatty acids is particularly high, it is advantageous to investigate changes in oxidative damage, and this experiment was conducted because the oxidation of lipid components has a deep relationship with cell membrane damage and other protein damage. Referring to FIG. 4, as a result of measuring lipid peroxidation inhibitory activity using mouse brain homogenate, addition of water extract of fermented black rice powder prepared using the fermented black rice powder of Example 1 is similar to the above two antioxidant activity results. As the concentration increased, lipid peroxidation in brain tissues was very inhibited, and in particular, the sample to which 1,000 μg/mL was added showed a very high lipid peroxidation inhibitory activity of 76.25%.
실험 5: 신경세포 생존율 측정 및 세포막 손상 억제 효과 측정Experiment 5: Measurement of neuronal cell viability and cell membrane damage inhibition effect
세포 및 배양방법Cell and culture method
본 실험에서 사용한 PC12 세포(KCLB 21721, Korean Cell Line Bank, Seoul, Korea)는 신경세포의 특성을 나타내는 세포로 쥐의 pheochromocytoma로부터 유도된 것을 사용하였다. PC12세포를 25 mM HEPES, 25 mM sodium bicarbonate, 10% fetal bovine serum (GIBCO), 50 units/mL penicillin 및 100 μg/mL streptomycin이 포함된 RPMI 1640배지에 접종하여 37℃, 5% CO2 조건의 배양기에서 배양하였다.PC12 cells (KCLB 21721, Korean Cell Line Bank, Seoul, Korea) used in this experiment were cells that exhibit neuronal characteristics and were derived from murine pheochromocytoma. Of the PC12 cells, 25 mM HEPES, 25 mM sodium bicarbonate , 10% fetal bovine serum (GIBCO), 50 units / mL penicillin and 100 μg / mL and streptomycin inoculated in RPMI 1640 medium is contained 37 ℃, 5% CO 2 conditions It was cultured in an incubator.
세포 생존율 측정Cell viability measurement
H2O2에 의해 유도된 PC12 세포에 대하여 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물의 보호효과는 MTT reduction assay로 측정하였다. 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물을 PC12 cell에 처리하여 48시간동안 pre-incubation 시킨 후, 200 μM H2O2를 각각 3시간 동안 처리하였다. 이 상태의 PC12 cell에 MTT stock solution을 처리하여 37℃에서 3시간 incubation 시킨 후, MTT solubilization solution 150 μL를 첨가하여 반응을 종결시켰다. 마지막으로 흡광도는 microplate reader (680, Bio-rad, Tokyo, Japan)에서 570 nm와 690 nm에서 측정하였다. Positive control은 vitamin C (200 μM)를 사용하였고, cell viability는 control group에 대한 % concentration으로 나타냈다(도 5 참조). The protective effect of the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 on PC12 cells induced by H 2 O 2 was measured by MTT reduction assay. The black rice fermented powder water extract according to concentration prepared using the black rice fermented powder of Example 1 was treated in PC12 cells and pre-incubated for 48 hours, followed by treatment with 200 μM H 2 O 2 for 3 hours, respectively. PC12 cells in this state were treated with MTT stock solution and incubated at 37°C for 3 hours, and then 150 μL of MTT solubilization solution was added to terminate the reaction. Finally, absorbance was measured at 570 nm and 690 nm in a microplate reader (680, Bio-rad, Tokyo, Japan). For the positive control, vitamin C (200 μM) was used, and the cell viability was expressed as a% concentration for the control group (see FIG. 5).
상기 실시예 1의 흑미 발효분말을 이용하여 제조한 농도별 흑미 발효분말 물추출물의 H2O2에 의해 유도된 산화적 스트레스 상태에서 PC12 신경세포에 대한 보호 효과를 측정한 결과, 도 5를 참조하면 세포생존율의 경우 H2O2를 처리한 처리구에서는 control group 100% 대비 58%의 생존율을 나타냈고 H2O2와 vitamin C를 동시에 처리한 처리구에서는 79%의 생존율로 약 21%정도의 신경세포 보호효과를 보였다. 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물을 처리한 시료에서는 200 μg/mL 농도에서 양성 대조구로 사용된 vitamin C 200 μM과 유사한 보호효과를 보였으며, 추출물의 첨가농도가 증가함에 따라 점차적으로 신경세포 보호효과가 유의적으로 증가하는 경향을 보였다. As a result of measuring the protective effect on PC12 neurons in a state of oxidative stress induced by H 2 O 2 of the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1, see FIG. 5 In the case of lower cell viability , treatment with H 2 O 2 showed a survival rate of 58% compared to 100% in the control group, and in the treatment group treated with H 2 O 2 and vitamin C at the same time, the survival rate of 79% was about 21%. It showed a cell protective effect. The sample treated with the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 showed a protective effect similar to 200 μM of vitamin C used as a positive control at a concentration of 200 μg/mL, and the added concentration of the extract As was increased, the neuronal protective effect showed a tendency to increase significantly.
세포막 손상 억제 효과Cell membrane damage inhibitory effect
상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물을 48시간동안 pre-incubation시킨 후, 200 μM H2O2를 처리하여 3시간 배양한 후, 5분간 원심분리(250 × g)하여 100 μL의 상등액을 새로운 well로 옮긴 후 LDH assay kit (Sigma Chemical Co., St. Louis, MO, USA)로 세포막 손상효과를 측정하였다(도 6 참조). The black rice fermented powder water extract prepared using the black rice fermented powder of Example 1 was pre-incubated for 48 hours , treated with 200 μM H 2 O 2 and cultured for 3 hours, and then centrifuged for 5 minutes (250 × g) After transferring 100 μL of the supernatant to a new well, the cell membrane damage effect was measured with an LDH assay kit (Sigma Chemical Co., St. Louis, MO, USA) (see FIG. 6).
신경세포의 경우 상대적으로 많은 lipid 성분을 함유하고 있고 이는 산화적인 스트레스에 매우 취약하기 때문에 이러한 구조적 특성을 이용하여 상기의 신경세포 보호효과와 신경세포막 손상과의 관계를 알아보고자 다음의 연구를 진행하였다. 도 6을 참조하면, H2O2로 유도된 신경세포막 손상에 대한 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물의 보호효과를 확인하기 위하여 신경세포 중에 함유되어 있는 세포질 성분의 LDH 방출량을 측정한 결과 control group의 방출량은 21% 정도인데 반해 H2O2 처리한 시료에서는 64%의 방출량을 보여 H2O2와 같은 산화적 스트레스로 인하여 LDH 방출량이 43%정도 증가하였다. 양성 대조군인 vitamin C 200 μM 처리군은 32%의 LDH 방출량을 보였고, 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물의 경우 12~200 μg/mL의 농도로 처리했을 때 38~23%로 LDH 방출량이 농도 의존적으로 감소하는 경향을 보였다. Neurons contain relatively many lipid components and are very susceptible to oxidative stress, so the following study was conducted to investigate the relationship between the above neuronal protective effect and neuronal cell membrane damage using these structural properties. . 6, the cytoplasm contained in nerve cells to confirm the protective effect of the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 against H 2 O 2 induced nerve cell membrane damage. As a result of measuring the LDH emission of the component, the emission of the control group was about 21%, whereas the H 2 O 2 treated sample showed a 64% emission, and the LDH emission increased by 43% due to oxidative stress such as H 2 O 2 I did. The positive
DCF-DA assayDCF-DA assay
상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물의 PC12 세포의 산화적 손상에 대한 보호효과를 측정하기 위하여 DCF-DA assay를 실시하였다. 먼저 세포를 96 well plate에 1×104 cells/well로 분주하고 37℃, 5% CO2의 조건에서 24시간동안 배양하였다. 흑미 발효분말 추출물을 PC12 cell에 처리하여 48시간동안 pre-incubation 시킨 후, 200 μM H2O2를 각각 3시간 동안 처리하였다. 배양 후 배지를 제거한 다음, phosphate buffered saline (PBS) buffer로 희석된 10 μM DCF-DA를 가하고, 45분간 배양하였다. PBS buffer로 2회 washing한 다음 200 μM H2O2를 가하고, 3시간 뒤에 fluorescence microplate reader를 사용하여, excitation파장 485 nm와 emission 파장 535 nm에서 형광강도를 측정하였다(도 7 참조).DCF-DA assay was performed to measure the protective effect of the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 against oxidative damage to PC12 cells. First, the cells were aliquoted into a 96 well plate at 1×10 4 cells/well and cultured for 24 hours at 37°C and 5% CO 2. The black rice fermented powder extract was treated with PC12 cells and pre-incubated for 48 hours, followed by treatment with 200 μM H 2 O 2 for 3 hours each. After incubation, the medium was removed, and then 10 μM DCF-DA diluted with phosphate buffered saline (PBS) buffer was added, followed by incubation for 45 minutes. After washing twice with PBS buffer, 200 μM H 2 O 2 was added, and after 3 hours, fluorescence intensity was measured at an excitation wavelength of 485 nm and an emission wavelength of 535 nm using a fluorescence microplate reader (see FIG. 7 ).
상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물의 H2O2에 의해 유도된 PC12 세포 내 ROS 생성 저해 활성을 측정한 결과, 도 7을 참조하면 DCF formation은 H2O2를 처리한 처리구에서는 control group 100% 대비 142%의 DCF formation을 나타냈고 H2O2와 vitamin C를 동시에 처리한 처리구에서는 104%로 약 38%정도의 산화적 스트레스 감소 효과를 보였다. 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물에서는 농도 의존적인 경향으로 H2O2 처리구에 비해 산화적 스트레스의 감소효과를 보였다. 농도 200 μg/mL에서는 105%로 양성 대조구로 사용된 vitamin C 200 μM(104%)과 유사한 산화적 스트레스 감소 효과를 보였다. 이는 흑미에 함유되어 있는 강력한 항산화 물질인 cyanidin-3-O-glucoside와 같은 안토시아닌계 화합물에 의한 것으로 판단된다. As a result of measuring the ROS production inhibitory activity in PC12 cells induced by H 2 O 2 of the black rice fermented powder water extract prepared using the black rice fermented powder of Example 1 , DCF formation is H 2 O The treatment group treated with 2 showed 142% of DCF formation compared to 100% of the control group, and 104% in the treatment group treated with H 2 O 2 and vitamin C at the same time showed an oxidative stress reduction effect of about 38%. The black rice fermented powder water extract prepared by using the black rice fermented powder of Example 1 showed a concentration-dependent tendency to reduce oxidative stress compared to the H 2 O 2 treatment group. At a concentration of 200 μg/mL, it was 105%, showing a similar oxidative stress reduction effect to
총 페놀성 화합물 및 cyanidin-3-O-glucoside 함량 분석Analysis of total phenolic compounds and cyanidin-3-O-glucoside content
흑미 발효분말에 함유되어 있는 총 페놀성 화합물 함량 분석을 위하여, 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물 1 mL에 3차 증류수 9 mL을 첨가한 후 Folin Ciocalteau phenol reagent 1 mL를 넣고 혼합하여 실온에서 5분간 반응시켰다. 반응용액에 7% Na2CO3 용액 10 mL를 넣어 다시 혼합한 다음 3차 증류수로 25 mL로 정용하였다. 이 혼합 용액을 23℃에서 2시간 동안 정치한 후 760 nm 에서 흡광도를 측정하였으며, 측정된 흡광도는 gallic acid를 이용하여 작성된 검량선으로 총 페놀화합물 함량을 계산하였다. 흑미 발효분말의 cyanidin-3-O-glucoside 함량 분석은 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물 2 mL를 0.45 μm membrane filter로 여과한 다음 HPLC(1100, Agillent Co., Santa clara, CA, USA)로 분석하였다. 분석조건 column은 shiseido C18(4.6 mm × 250 mm, 5 μm)을 사용하였고, 이동상은 0.01 M potassium phosphate monobasic(pH 3.0)와 80% methanol로 30분 동안 선형 기울기 분석을 하였다. 유속은 1.5 mL/min, 주입량은 20 μL, 검출기는 diode array detector 및 파장은 530 nm에서 분석하였다.For the analysis of the total phenolic compound content contained in the fermented black rice powder, 9 mL of tertiary distilled water was added to 1 mL of the water extract of the fermented black rice powder prepared using the fermented black rice powder of Example 1, and then Folin Ciocalteau phenol reagent. 1 mL was added, mixed, and reacted at room temperature for 5 minutes. 10 mL of a 7% Na 2 CO 3 solution was added to the reaction solution, mixed again, and then distilled to 25 mL with tertiary distilled water. The mixed solution was allowed to stand at 23°C for 2 hours, and the absorbance was measured at 760 nm, and the measured absorbance was calculated using a calibration curve prepared using gallic acid to calculate the total phenolic compound content. For the analysis of cyanidin-3-O-glucoside content in the fermented black rice powder, 2 mL of the water extract of the black rice fermented powder prepared using the black rice fermented powder of Example 1 was filtered through a 0.45 μm membrane filter, followed by HPLC (1100, Agillent Co. , Santa clara, CA, USA). Analysis condition column was used as shiseido C18 (4.6 mm × 250 mm, 5 μm), and the mobile phase was linear gradient analysis for 30 minutes with 0.01 M potassium phosphate monobasic (pH 3.0) and 80% methanol. The flow rate was 1.5 mL/min, the injection amount was 20 μL, the detector was a diode array detector, and the wavelength was analyzed at 530 nm.
구체적인 실험 결과, 상기 실시예 1의 흑미 발효분말을 이용하여 제조한 흑미 발효분말 물추출물 1 g에 함유되어 있는 총 페놀성 화합물 함량 및 cyanidin-3-O-glucoside 함량은 각각 44.27 mg/g GAE 및 30.61 mg/g이었다.As a result of specific experiments, the total phenolic compound content and cyanidin-3-O-glucoside content contained in 1 g of the water extract of the fermented black rice powder prepared using the fermented black rice powder of Example 1 were 44.27 mg/g GAE and respectively. It was 30.61 mg/g.
이상으로 설명한 바와 같이, 본 발명에 따라 제조된 흑미 발효분말은 항산화능을 가지며, 세포의 산화적 손상을 방지하는 효과가 있다. 특히, 본 발명에 따른 흑미 발효분말은 신경세포 보호능을 가지는 것으로 확인되었다. As described above, the fermented black rice powder prepared according to the present invention has antioxidant properties and has an effect of preventing oxidative damage to cells. In particular, it was confirmed that the fermented black rice powder according to the present invention has the ability to protect nerve cells.
앞에서, 본 발명의 특정한 실시예가 설명되고 도시되었지만 본 발명은 기재된 실시예에 한정되는 것이 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명한 일이다. 따라서, 그러한 수정예 또는 변형예들은 본 발명의 기술적 사상이나 관점으로부터 개별적으로 이해되어서는 안되며, 변형된 실시예들은 본 발명의 특허청구범위에 속한다 하여야 할 것이다.In the above, although specific embodiments of the present invention have been described and illustrated, the present invention is not limited to the described embodiments, and various modifications and variations can be made without departing from the spirit and scope of the present invention. It is self-evident to those who have. Accordingly, such modifications or variations should not be individually understood from the technical spirit or viewpoint of the present invention, and the modified embodiments should be said to belong to the claims of the present invention.
Claims (7)
상기 배합 시 분말 전체 중량을 기준으로 흑미 분말은 20 내지 30wt%, 단백 분말은 20 내지 30wt%, 정제수는 45 내지 55wt% 및 동결 건조된 류코노스톡 메센테로이데스(Leuconostoc mesenteroides) 유산균 분말은 0.005 내지 0.015 wt%로 배합되고,
상기 발효 시 발효 온도는 35 내지 37℃이며,
상기 발효 단계 후, 상기 발효분말을 동결 건조한 다음, 분쇄하는 단계를 더 포함하는, 흑미 발효분말의 제조방법으로서,
상기 제조되는 흑미 발효분말은 유산균 함량이 1,000,000 cfu/g 이상이고,
상기 발효분말은 지질과산화 억제활성을 통한 항산화능 또는 신경세포 보호능을 가져, 동맥경화, 당뇨병 및 고혈압 중 선택되는 1종 이상의 질환에 대한 치료 또는 예방 용도를 가지는, 흑미 발효분말의 제조방법.
Blending black rice powder, protein powder, purified water, and freeze-dried Leuconostoc mesenteroides lactic acid bacteria powder, and fermenting for 20 to 40 days,
When blended, based on the total weight of the powder, black rice powder is 20 to 30 wt%, protein powder is 20 to 30 wt%, purified water is 45 to 55 wt%, and freeze-dried Leuconostoc mesenteroides lactic acid bacteria powder is 0.005 to Blended at 0.015 wt%,
The fermentation temperature during the fermentation is 35 to 37 ℃,
After the fermentation step, freeze-drying the fermented powder, and then pulverizing the fermented powder as a method for producing a fermented black rice powder, further comprising,
The prepared black rice fermented powder has a lactic acid bacteria content of 1,000,000 cfu/g or more,
The fermented powder has antioxidant activity or nerve cell protection through lipid peroxidation inhibitory activity, and has a therapeutic or preventive use for at least one disease selected from arteriosclerosis, diabetes and hypertension.
상기 분쇄 단계 후, 얻어진 발효분말의 직경은 250 μm 이하인, 흑미 발효분말의 제조방법.
The method of claim 1,
After the pulverizing step, the diameter of the obtained fermented powder is 250 μm or less, a method for producing black rice fermented powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190013020A KR102222846B1 (en) | 2019-01-31 | 2019-01-31 | Fermented black rice powder having antioxidant ability or nerve cell protective ability and the method for manufacturing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190013020A KR102222846B1 (en) | 2019-01-31 | 2019-01-31 | Fermented black rice powder having antioxidant ability or nerve cell protective ability and the method for manufacturing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200095211A KR20200095211A (en) | 2020-08-10 |
KR102222846B1 true KR102222846B1 (en) | 2021-03-04 |
Family
ID=72049151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190013020A KR102222846B1 (en) | 2019-01-31 | 2019-01-31 | Fermented black rice powder having antioxidant ability or nerve cell protective ability and the method for manufacturing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102222846B1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101157867B1 (en) * | 2010-04-02 | 2012-06-22 | 주식회사 웰빙엘에스 | Probiotic grain fermentation and preparation method thereof |
-
2019
- 2019-01-31 KR KR1020190013020A patent/KR102222846B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20200095211A (en) | 2020-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lin et al. | Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria | |
KR101774414B1 (en) | Composition for improving skin condition comprising exopolysaccharide produced by ceriporia lacerata as an active ingredient | |
KR101103283B1 (en) | The Manufacturing Method of Fermented Aloe for Whitening Effect in skin, and the Functional Whitening Cosmetics Containing Fermented Aloe | |
Jing et al. | Antioxidant activity, antitumor effect, and antiaging property of proanthocyanidins extracted from Kunlun Chrysanthemum flowers | |
KR20170054682A (en) | Soybean fermented composition having enhanced physiological activity and health functional food for alleviating climacteric or menopausal syndrome comprising the same | |
KR20150039263A (en) | Cosmetic composition containing fermented herb extracts and marine derived materials | |
KR20200054864A (en) | Complex-fermented composition of Fabaton soybean leaves and Schisandra chinensis having enhanced anti-diabetic and anti-obesity effects and preparation method thereof | |
KR20070079465A (en) | Fermented extract of citrus sunkii hort, method for processing thereof, and use | |
KR101819060B1 (en) | Cosmetic Compositions Containing Fermented Extracts of Hwangryunhaedoktang | |
Nawwar et al. | Constitutive phenolics of Harpephyllum caffrum (Anacardiaceae) and their biological effects on human keratinocytes | |
Lin et al. | Antioxidant properties and antibacterial activity of fermented Monascus purpureus extracts | |
KR100755515B1 (en) | Functional drinks using Salicornia herbacea and a method of manufacturing process | |
KR102359165B1 (en) | Dendropanax morbifera complex extracts for improving liver and kidney, Manufacturing method thereof and Health functional food containing the same | |
KR102222846B1 (en) | Fermented black rice powder having antioxidant ability or nerve cell protective ability and the method for manufacturing the same | |
KR102251825B1 (en) | Composition to inhibit liver damage using mushroom mycelia germinated on naked barley medium and Manufacturing method thereof | |
JPH11228441A (en) | Antioxidant function potentiator for living body | |
KR102078671B1 (en) | A aronia beverage composition having the increased antioxidation, skin whitening, and anti-wrinkle effects | |
KR20200098153A (en) | Composition for preventing or improving of skin wrinkle or skin photo-aging comprising fermented extract of Dendropanax morbifera and purple sweet potato as an active ingredient | |
KR20190030850A (en) | Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof | |
KR102464052B1 (en) | Composition of complex-fermented sprout ginseng having increased ginsenoside F2, Rg3, Rd2 and compound K, chlorogenic acid, coumaric acid, catechin and quercetin, and preparation method thereof | |
Mlozen et al. | In Vitro Effects of Annona Senegalensis Root Bark, Musa Sapientum L and Malus Pumila Peel Extracts on Xanthine Oxidase | |
KR101203096B1 (en) | Producing method for fermented wild grass extracts with biological activity | |
KR100608141B1 (en) | Buckwheat fermented with fungi Monascus species | |
KR101924317B1 (en) | Preparing method for boiled salt comprising lindera obtusiloba | |
KR100517354B1 (en) | Oligo saccharides induced from seaweeds, method for producing the oligo saccharides and use of the oligosaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |